An Act relative to APOL1 mediated kidney disease
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill addresses kidney disease linked to a specific gene, APOL1. It aims to increase understanding and potentially improve treatment strategies for individuals at risk of developing end-stage renal disease due to this genetic factor. The legislation supports a study to further investigate the causes and potential interventions related to APOL1 mediated kidney disease. It is part of a series of bills focused on improving access to Medicare coverage for kidney disease patients.
Key provisions
- Supports a study to investigate APOL1 mediated kidney disease.
- Aims to enhance understanding of the genetic factors contributing to kidney disease.
- Related to existing legislation concerning Medicare coverage for end-stage renal disease (H.4425 and S.2737).
- Part of a series of bills addressing APOL1 mediated kidney disease (S.1545).
Who is affected
- Individuals at risk of developing end-stage renal disease
- Patients with APOL1 mediated kidney disease
- Healthcare providers involved in kidney disease treatment
- Researchers studying kidney disease genetics
Notable changes
- The bill is part of a broader effort to improve Medicare coverage for kidney disease patients.
- It is linked to other bills (H.4425 and S.2737) concerning Medicare coverage.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
5 on record
Primary sponsor
Homar Gómez
Cosponsors
Homar Gómez
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours